Tebra, the all-in-one EHR+ platform serving independent healthcare providers, has secured $250 million in new equity and debt financing, reinforcing its ambition to become a defining force in AI-driven practice management. The over-subscribed round was led by healthcare-focused private equity firm Hildred, with a debt facility provided by J.P. Morgan.
The financing round also saw strong participation from existing investors, including Toba Capital, Transformation Capital, and HLM Venture Partners, signaling continued confidence in Tebra’s long-term strategy and market leadership.
Founded to serve the unique needs of private medical practices, Tebra currently supports more than 140,000 healthcare providers and manages over 125 million patient records. The company plans to deploy the new capital toward accelerating AI and automation across clinical documentation, revenue cycle management, patient engagement, and practice marketing.
Redefining healthcare software for independent providers
Unlike legacy electronic health record systems, Tebra positions its EHR+ offering as a “System of Action” rather than a static system of record. The platform is designed to actively reduce administrative burden by automating workflows, minimizing errors, and simplifying operations for clinicians and staff navigating rising costs and shrinking reimbursements.
“Independent practices are the backbone of the U.S. healthcare system, yet they have been historically underserved by legacy technology that adds to their administrative burden rather than alleviating it,” said Andrew Goldman, Co-Founder and Managing Partner at Hildred. He added that Tebra’s AI-enabled platform represents a meaningful shift toward restoring profitability and allowing providers to refocus on patient care.
AI as a strategic equalizer
For Tebra, artificial intelligence is central to its roadmap. The company intends to rapidly scale AI-powered tools that improve provider efficiency, strengthen revenue recovery, and support sustainable practice growth. These include solutions for automated clinical note generation, intelligent billing and coding, denial prevention, patient communications, and AI-driven reputation and marketing management.
“This investment is a direct mandate to eliminate the ‘squeeze’ on private practices,” said Dan Rodrigues, Founder and Chief Executive Officer of Tebra. “AI represents the great equalizer for the industry, solving systemic challenges that cause burnout and erode profitability. Our confidence—shared by our investors—comes from our ability to embed AI deeply into an all-in-one platform built specifically for independent practices.”
Positioned for scale and long-term impact
With a profitable core business and a diversified go-to-market engine, Tebra now enters its next phase with both financial strength and operational momentum. The company aims to expand adoption among private practices while continuing to monetize its large installed base through advanced AI capabilities.
Legal and advisory support for the transaction included Kirkland & Ellis LLP advising Hildred, while Jefferies served as exclusive financial advisor and Fenwick & West LLP acted as legal counsel to Tebra.
Editorial View: Why Tebra’s Trajectory Matters
The healthcare technology sector is entering a decisive era where efficiency, automation, and financial sustainability are no longer optional for independent practices. In this environment, Tebra’s strategy stands out for its clarity of purpose: addressing the operational realities clinicians face daily rather than retrofitting enterprise tools designed for large hospital systems.
By embedding AI across clinical, financial, and growth workflows, Tebra is aligning technology innovation with provider well-being and economic resilience. This approach not only enhances productivity but also tackles burnout—one of the most pressing challenges in modern healthcare.
Looking ahead, the scale of this funding and the caliber of investors such as Hildred suggest that Tebra is well-positioned to influence how independent care is delivered, managed, and sustained. If execution continues to match ambition, the company could play a pivotal role in shaping a more balanced and AI-enabled healthcare ecosystem.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
